简介：VEGFR Tyrosine Kinase Inhibitor II是一种有效的血管生成抑制剂,KDR、Flt-1、c-Kit、EGF-R和c-Src的IC50分别为0.02、0.18、0.24、7.3和7µM[1]。VEGFR Tyrosine Kinase Inhibitor II物理化学性质：VEGFR Tyrosine Kinase Inhibitor II详细介绍：VEGFR Tyrosine Kinase Inhibitor II参考文献：[1]. Fur...
英文名称:VEGFRTyrosineKinaseInhibitorII 品牌:MedBio 分子式:C19H16ClN3O 货号:MED19478 产地:上海 纯度:98% 是否进口:否 产品用途:VEGFR抑制剂 更多产品规格请登录MedBio官网或者联系我们。MedBio为生命科学和医药研发人员提供3W+抑制剂、激动剂、荧光探针、mRNA转录、生物化工、无毒染料、医药中间体、植物提取物、IV...
简介:VEGFR Tyrosine Kinase Inhibitor II是一种有效的血管生成抑制剂,KDR、Flt-1、c-Kit、EGF-R和c-Src的IC50分别为0.02、0.18、0.24、7.3和7µM[1]。 VEGFR Tyrosine Kinase Inhibitor II物理化学性质: 分子式:C19H16ClN3O 分子量:337.803 精确质量:337.098 PSA:54.02 LogP:4.7454 VEGFR Tyrosine Kinase ...
产品名:VEGFR酪氨酸激酶抑制剂II 纯度:98.0% 规格: 联系人:徐经理 联系电话:13311869306 上海脉铂医药科技有限公司 上海市上海市嘉定区 产品名:VEGFR Tyrosine Kinase Inhibitor II 产品网址:http://www.med-bio.cn/product/7972.html 纯度:98.0% 规格:5mg/1mg/1g/1g ...
E7050: A dual c-Met and VEGFR-2 tyrosine kinase inhibitor promotes tumor regression and prolongs survival in mouse xenograft models. Cancer Sci. 2010, 101, 210-215. [CrossRef] [PubMed]Nakagawa T, Tohyama O, Yamaguchi A, Matsushima T, Takahashi K, Funasaka S, et al. E7050: a dual ...
产品名称:VEGFR/Tie-2/PDGFR Tyrosine Kinase Inhibitor .0订购此产品 供应商:Merck 规格:PC 目录价:1346 库存状态:3周到货 CAS编号: 应用范围:生化实验 种属来源: 相关信息: VEGFR/Tie-2/PDGFR Tyrosine Kinase Inhibitor 1-(2-Fluoro-4-((5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy)phenyl)-3-(...
Names: Ki8751;VEGFR-2 tyrosine kinase inhibitorCAS号: 228559-41-9 MDL Number: MF(分子式): C24H18F3N3O4 MW(分子量): 469.41EINECS:Not available Reaxys Number:No data available Pubchem ID:11317348 Brand:BIOFOUNT Ki8751是一种有效的口服VEGFR2激酶活性抑制剂(IC50 = 0.9 nM)。它抑制c-Kit,PDGRF...
5. Melichar B, Studentová H, Zezulová M .Pazopanib: a new multiple tyrosine kinase inhibitor in the therapy of metastatic renal cell carcinoma and other solid tumors. J BUON. 2011 Apr-Jun;16(2):203-9. 6. Jamil MO, Hathaway A , Mehta A...
R1530 is also a mitosis-angiogenesis inhibitor (MAI) that inhibits multiple receptor tyrosine kinases involved in angiogenesis, such as vascular endothelial growth factor receptor (VEGFR)-1, -2, -3, platelet-derived growth factor receptor (PDGFR) beta FMS-like tyrosine kinase (Flt)-3, and ...
A nicotinamide-based derivative was designed as an antiproliferative VEGFR-2 inhibitor with the key pharmacophoric features needed to interact with the VEGFR-2 catalytic pocket. The ability of the designed congener ((E)-N-(4-(1-(2-(4-benzamidobenzoyl)hydrazono)ethyl)phenyl)nicotinamide), compo...